Literature DB >> 27188917

Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.

O Helk1, R Schreiber2, K Widhalm1.   

Abstract

BACKGROUND/
OBJECTIVE: Subjects suffering from lipoprotein lipase (LPL) deficiency show very severe hypertriglyceridemia, often accompanied by recurrent bouts of pancreatitis. Dietary intervention is currently considered first-line treatment of this condition in paediatric age. The aim of our study was to compare the effects of dietary treatment with a low-fat diet alone and a low-fat diet enriched with omega-3-fatty acids. SUBJECTS/
METHODS: The data of 11 patients with LPL deficiency who were diagnosed in our lipid clinic between October 1997 and October 2007 were summarised. All patients had been treated with a low-fat diet, and in addition a group of five patients received supplements of omega-3-fatty acids over a period of at least 5 months.
RESULTS: After adjustment for pre-intervention TG concentration, there was a statistically significant difference in post-intervention TG concentrations between the interventions, F(1,8)=13.529, P=0.006, partial η2=0.628. Post-intervention-adjusted TG concentrations were statistically significantly greater in the low-fat diet group vs the w3 diet group (P <0.05).
CONCLUSIONS: We provide first evidence that a low-fat diet supplemented with omega-3-fatty acids results in a pronounced decrease in TG in paediatric patients affected with LPL deficiency. However, further studies are necessary to evaluate the long-term effects and safety of omega-3-fatty acids.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27188917     DOI: 10.1038/ejcn.2016.70

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  28 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis.

Authors:  J S Partin; J C Partin; W K Schubert; A J McAdams
Journal:  Gastroenterology       Date:  1974-07       Impact factor: 22.682

3.  Hypertriglyceridemia.

Authors:  Rade N Pejic; Daniel T Lee
Journal:  J Am Board Fam Med       Date:  2006 May-Jun       Impact factor: 2.657

4.  Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.

Authors:  M Rouis; K A Dugi; L Previato; A P Patterson; J D Brunzell; H B Brewer; S Santamarina-Fojo
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-07       Impact factor: 8.311

5.  Treatment of primary chylomicronemia due to familial hypertriglyceridemia by omega-3 fatty acids.

Authors:  W O Richter; B G Jacob; M M Ritter; P Schwandt
Journal:  Metabolism       Date:  1992-10       Impact factor: 8.694

Review 6.  Lipid screening and cardiovascular health in childhood.

Authors:  Stephen R Daniels; Frank R Greer
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

7.  Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.

Authors:  K Shirai; J Kobayashi; H Inadera; Y Ohkubo; S Mori; Y Saito; S Yoshida
Journal:  Metabolism       Date:  1992-11       Impact factor: 8.694

8.  Abetalipoproteinemia. Report of two cases and review of therapy.

Authors:  D R Illingworth; W E Connor; R G Miller
Journal:  Arch Neurol       Date:  1980-10

9.  Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance.

Authors:  Yongsoon Park; William S Harris
Journal:  J Lipid Res       Date:  2002-12-01       Impact factor: 5.922

10.  Effectiveness of omega-3 polysaturated fatty acids (fish oil) supplementation for treating hypertriglyceridemia in children and adolescents.

Authors:  Nita Chahal; Cedric Manlhiot; Helen Wong; Brian W McCrindle
Journal:  Clin Pediatr (Phila)       Date:  2014-03-18       Impact factor: 1.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.